Tag Archives: MorphoSys

November, 2018

September, 2018

March, 2015

  • 27 March

    Celgene Ends its Blood Cancer Collaboration with MorphoSys

    MorphoSys AG and Celgene announced that the companies have mutually decided to terminate their co-development and co-promotion agreement for an investigational blood cancer drug. In a press release, MorphoSys said that it has regained rights to MOR202 from Celgene. The news sent MorphoSys shares down 20 percent, its biggest drop …